tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Oppenheimer maintains bullish stance on Corteva following split reports
The FlyOppenheimer maintains bullish stance on Corteva following split reports
4d ago
CTVA
Morgan Stanley says Corteva may want to get out in front of ag landscape changes
PremiumThe Fly
Morgan Stanley says Corteva may want to get out in front of ag landscape changes
4d ago
CTVA
Bayer announces new drug application for gadoquatrane accepted for review by FDA
PremiumThe Fly
Bayer announces new drug application for gadoquatrane accepted for review by FDA
23d ago
Bayer AG’s New Pediatric Study: A Closer Look at Rivaroxaban for VTE
PremiumCompany Announcements
Bayer AG’s New Pediatric Study: A Closer Look at Rivaroxaban for VTE
28d ago
Bayer AG’s Promising Phase 3 Study on Prostate Cancer Treatment
PremiumCompany Announcements
Bayer AG’s Promising Phase 3 Study on Prostate Cancer Treatment
28d ago
Bayer’s New Clinical Study on HER2-Targeted Cancer Treatment: A Potential Game Changer
PremiumCompany AnnouncementsBayer’s New Clinical Study on HER2-Targeted Cancer Treatment: A Potential Game Changer
28d ago
Bayer AG’s Exploratory Study on Sepsis and DIC: A Potential Game Changer?
Premium
Company Announcements
Bayer AG’s Exploratory Study on Sepsis and DIC: A Potential Game Changer?
28d ago
Bayer AG’s Innovative Phase I Study: A New Frontier in Cancer Treatment
Premium
Company Announcements
Bayer AG’s Innovative Phase I Study: A New Frontier in Cancer Treatment
28d ago
Bayer’s Observational Study on Darolutamide: A Potential Game-Changer for Prostate Cancer Treatment
PremiumCompany Announcements
Bayer’s Observational Study on Darolutamide: A Potential Game-Changer for Prostate Cancer Treatment
28d ago
Bayer’s Darolutamide Safety Study in Korea: Key Insights for Investors
PremiumCompany Announcements
Bayer’s Darolutamide Safety Study in Korea: Key Insights for Investors
28d ago
Bayer’s Pediatric Study on Rivaroxaban: A Potential Game-Changer for VTE Treatment
PremiumCompany Announcements
Bayer’s Pediatric Study on Rivaroxaban: A Potential Game-Changer for VTE Treatment
1M ago
Bayer’s New Study on Darolutamide: A Potential Game-Changer in Prostate Cancer Treatment
PremiumCompany Announcements
Bayer’s New Study on Darolutamide: A Potential Game-Changer in Prostate Cancer Treatment
1M ago
Bayer’s Phase 2 Study on BAY2927088: A Potential Game-Changer in HER2-Positive Tumor Treatment
PremiumCompany AnnouncementsBayer’s Phase 2 Study on BAY2927088: A Potential Game-Changer in HER2-Positive Tumor Treatment
1M ago
Bayer AG’s Regorafenib Study: A Potential Game-Changer in Cancer Treatment
Premium
Company Announcements
Bayer AG’s Regorafenib Study: A Potential Game-Changer in Cancer Treatment
1M ago
Bayer AG Advances Parkinson’s Treatment with Promising Gene Therapy Study
Premium
Company Announcements
Bayer AG Advances Parkinson’s Treatment with Promising Gene Therapy Study
1M ago
Bayer’s SMART-Finder Study: A Closer Look at T2DM and Kidney Health
PremiumCompany Announcements
Bayer’s SMART-Finder Study: A Closer Look at T2DM and Kidney Health
1M ago
Bayer’s First-in-Human Study on BAY 3713372: A Potential Game-Changer for MTAP-deleted Tumors
PremiumCompany Announcements
Bayer’s First-in-Human Study on BAY 3713372: A Potential Game-Changer for MTAP-deleted Tumors
1M ago
AstraZeneca and Bayer’s Promising Prostate Cancer Study: Key Insights for Investors
PremiumCompany Announcements
AstraZeneca and Bayer’s Promising Prostate Cancer Study: Key Insights for Investors
1M ago
AZN
Bayer’s Phase 2 Parkinson’s Study: A Potential Game-Changer in Gene Therapy
PremiumCompany Announcements
Bayer’s Phase 2 Parkinson’s Study: A Potential Game-Changer in Gene Therapy
1M ago
Bayer’s SMART-Finder Study: A New Frontier in Diabetes and Kidney Health
PremiumCompany AnnouncementsBayer’s SMART-Finder Study: A New Frontier in Diabetes and Kidney Health
1M ago
Bayer’s Prostate Cancer Study: Insights on Medication Adherence and Market Impact
Premium
Company Announcements
Bayer’s Prostate Cancer Study: Insights on Medication Adherence and Market Impact
1M ago
Bayer’s Latest Clinical Study on Prostate Cancer Treatment: Key Insights for Investors
Premium
Company Announcements
Bayer’s Latest Clinical Study on Prostate Cancer Treatment: Key Insights for Investors
1M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >